New Zealand Clinical Oncology NGS Market (2025-2031) | Industry, Share, Forecast, Companies, Outlook, Growth, Competitive Landscape, Segmentation, Analysis, Size & Revenue, Trends, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 New Zealand Country Macro Economic Indicators

3.2 New Zealand Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 New Zealand Clinical Oncology NGS Market - Industry Life Cycle

3.4 New Zealand Clinical Oncology NGS Market - Porter's Five Forces

3.5 New Zealand Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 New Zealand Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.7 New Zealand Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 New Zealand Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer cases in New Zealand

4.2.2 Growing adoption of precision medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) technologies

4.3 Market Restraints

4.3.1 High cost associated with NGS testing

4.3.2 Limited reimbursement policies for NGS-based oncology testing

4.3.3 Data privacy and security concerns related to genomic data

6.1 New Zealand Clinical Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.1.5 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F

6.2 New Zealand Clinical Oncology NGS Market, By Workflow

6.2.1 Overview and Analysis

6.2.2 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.2.3 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.2.4 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F

6.3 New Zealand Clinical Oncology NGS Market, By Application

6.3.1 Overview and Analysis

6.3.2 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F

6.3.3 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.3.4 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F

6.4 New Zealand Clinical Oncology NGS Market, By End-use

6.4.1 Overview and Analysis

6.4.2 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 New Zealand Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F

7.1 New Zealand Clinical Oncology NGS Market Export to Major Countries

7.2 New Zealand Clinical Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing in clinical oncology

8.2 Rate of adoption of NGS-based oncology testing in healthcare facilities

8.3 Number of clinical trials incorporating NGS technology for oncology research

9.1 New Zealand Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 New Zealand Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.3 New Zealand Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 New Zealand Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 New Zealand Clinical Oncology NGS Market Revenue Share, By Companies, 2024

10.2 New Zealand Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters